Obesity Surgery

, Volume 27, Issue 4, pp 917–925 | Cite as

Differential Changes in Gut Microbiota After Gastric Bypass and Sleeve Gastrectomy Bariatric Surgery Vary According to Diabetes Remission

  • Rinki Murphy
  • Peter Tsai
  • Mia Jüllig
  • Amy Liu
  • Lindsay Plank
  • Michael Booth
Original Contributions



It is unclear whether specific gut microbiota is associated with remission of type 2 diabetes (T2D) after distinct types of bariatric surgery.


The aim of this study is to examine gut microbiota changes after laparoscopic Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) surgery in obese patients with T2D.


Whole-metagenome shotgun sequencing of DNA fragments using Illumina HiSeq2000 was obtained from stool samples collected from 14 obese T2D patients pre-operatively (while on very low calorie diet) and 1 year after randomisation to laparoscopic SG (n = 7) or RYGB (n = 7). Resulting shotgun reads were annotated with Kyoto Encyclopedia of Genes and Genomes (KEGG).


Body weight reduction and dietary change was similar 1 year after both surgery types. Identical proportions (n = 5/7) achieved diabetes remission (HbA1c < 48 mmol/mol without medications) 1 year after RYGB and SG. RYGB resulted in increased Firmicutes and Actinobacteria phyla but decreased Bacteroidetes phyla. SG resulted in increased Bacteroidetes phyla. Only an increase in Roseburia species was observed among those achieving diabetes remission, common to both surgery types. KEGG Orthology and pathway analysis predicted contrasting and greater gut microbiota metabolism changes after diabetes remission following RYGB than after SG. Those with persistent diabetes post-operatively had higher Desulfovibrio species pre-operatively.


Overall, RYGB produces greater and more predicted favourable changes in gut microbiota functional capacity than SG. An increase in Roseburia species was the only compositional change common to both types of surgery among those achieving diabetes remission.


Gut microbiota Metagenome shotgun sequencing Bariatric surgery Sleeve gastrectomy Roux-en-Y gastric bypass 



The results from this study were presented at the annual European Association for the Study of Diabetes meeting in Stockholm in September 2015. We acknowledge the assistance of Wafa Elasheg (University of Auckland) and Greg Smith (University of Auckland) for their assistance with collecting samples for this study. We are grateful to the surgical and diabetes teams at North Shore Hospital involved in the successful conduct of the randomized clinical trial. We acknowledge New Zealand Genomics Limited for the high-throughput sequencing facility.

Authors’ Contributions

RM designed the research and drafted the manuscript. PT performed the bioinformatics analysis. MJ performed the pathway analysis. AL analysed the food diary data. LP supervised the clinical assessments including body composition and resting energy expenditure analysis. MB performed the surgeries and provided oversight of the clinical trial. All authors contributed to the interpretation of the data and approved the final manuscript.

Compliance with Ethical Standards

Conflict of Interest

No authors have any conflicts to disclose.

Ethical Approval

All study procedures were in accordance with the ethical standards of the national research ethics committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Grant Support

Maurice Wilkins Centre for Molecular Biodiscovery: Flexible research seeding programme funded biospecimen collection and analysis for the gut microbiota and gut hormone sub-study. We acknowledge funding support for the main clinical trial from Waitemata District Health Board, which provides limited publically funded bariatric surgery. Funding for blood sample storage and a research nurse salary was provided by Johnson and Johnson (NZ), Covidien (NZ) and Obex (NZ). DEXA scanning for body composition was provided by the Diabetes Research Fund (NZ), and Maurice & Phyllis Paykel Trust (NZ). No funders had any role in study design, data analysis or interpretation.

Supplementary material

11695_2016_2399_MOESM1_ESM.docx (115 kb)
Supplementary Figure 1(DOCX 114 kb)
11695_2016_2399_MOESM2_ESM.docx (388 kb)
Supplementary Figure 2(DOCX 388 kb)
11695_2016_2399_MOESM3_ESM.pdf (35 kb)
Supplementary Figure 3(PDF 35 kb)


  1. 1.
    Liou AP, Paziuk M, Luevano Jr JM, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5:178ra41.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Tremaroli V, Karlsson F, Werling M, et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 2015;22:228–38.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010;59:3049–57.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009;106:2365–70.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Graessler J, Qin Y, Zhong H, et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. The pharmacogenomics journal. 2013;13:514–22.CrossRefPubMedGoogle Scholar
  6. 6.
    Kong LC, Tap J, Aron-Wisnewsky J, et al. Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr. 2013;98:16–24.CrossRefPubMedGoogle Scholar
  7. 7.
    Ward EK, Schuster DP, Stowers KH, et al. The effect of PPI use on human gut microbiota and weight loss in patients undergoing laparoscopic roux-en-Y gastric bypass. Obes Surg. 2014;24:1567–71.CrossRefPubMedGoogle Scholar
  8. 8.
    Damms-Machado A, Mitra S, Schollenberger AE, et al. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed Res Int. 2015;2015:806248.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Scott KP, Gratz SW, Sheridan PO, et al. The influence of diet on the gut microbiota. Pharmacological research: the official journal of the Italian Pharmacological. Society. 2013;69:52–60.Google Scholar
  10. 10.
    GD W, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334:105–8.CrossRefGoogle Scholar
  11. 11.
    De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010;107:14691–6.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Walker AW, Ince J, Duncan SH, et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. The ISME journal. 2011;5:220–30.CrossRefPubMedGoogle Scholar
  13. 13.
    Andreu A, Moize V, Rodriguez L, et al. Protein intake, body composition, and protein status following bariatric surgery. Obes Surg. 2010;20:1509–15.CrossRefPubMedGoogle Scholar
  14. 14.
    Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490:55–60.CrossRefPubMedGoogle Scholar
  15. 15.
    Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498:99–103.CrossRefPubMedGoogle Scholar
  16. 16.
    Forslund K, Hildebrand F, Nielsen T et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 2015.Google Scholar
  17. 17.
    Zhang X, Zhao Y, Xu J, et al. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Scientific reports. 2015;5:14405.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Murphy R, Evennett NJ, Clarke MG, et al. Sleeve gastrectomy versus roux-en-Y gastric bypass for type 2 diabetes and morbid obesity: double-blind randomised clinical trial protocol. BMJ Open. 2016;6:e011416.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32:2133–5.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet journal. 2011;17:1–10.CrossRefGoogle Scholar
  21. 21.
    Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26:2460–1.CrossRefPubMedGoogle Scholar
  22. 22.
    Abubucker S, Segata N, Goll J, et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput Biol. 2012;8:e1002358.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480–4.CrossRefPubMedGoogle Scholar
  25. 25.
    Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–31.CrossRefPubMedGoogle Scholar
  26. 26.
    Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101:15718–23.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Ley RE, Backhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102:11070–5.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Collado MC, Isolauri E, Laitinen K, Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr. 2008;88:894–9.PubMedGoogle Scholar
  29. 29.
    Schwiertz A, Taras D, Schafer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2010;18:190–5.CrossRefGoogle Scholar
  30. 30.
    Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143:913–6 e7.CrossRefPubMedGoogle Scholar
  31. 31.
    Tolhurst G, Heffron H, Lam YS, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61:364–71.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Samuel BS, Shaito A, Motoike T, et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A. 2008;105:16767–72.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Zeevi D, Korem T, Zmora N, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163:1079–94.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Rinki Murphy
    • 1
  • Peter Tsai
    • 2
  • Mia Jüllig
    • 3
  • Amy Liu
    • 4
  • Lindsay Plank
    • 5
  • Michael Booth
    • 6
  1. 1.Department of Medicine, Faculty of Medical and Health SciencesUniversity of AucklandAucklandNew Zealand
  2. 2.Department of Bioinformatics, Faculty of Medical and Health SciencesUniversity of AucklandAucklandNew Zealand
  3. 3.School of Biological SciencesUniversity of AucklandAucklandNew Zealand
  4. 4.Auckland Diabetes CentreGreenlane Clinical CentreAucklandNew Zealand
  5. 5.Department of Surgery, Faculty of Medical and Health SciencesUniversity of AucklandAucklandNew Zealand
  6. 6.Department of SurgeryNorth Shore HospitalAucklandNew Zealand

Personalised recommendations